José Luis Pontones Moreno
José Luis Pontones Moreno
UROLOGY SPECIALIST PHYSICIAN
See more specialists on
Valenciavalencia
en/medical-staff/urologist
Dr. José Luis Pontones Moreno is a leading specialist in Urology , currently affiliated with H.QS. Valencia , where he practices as a specialist in his field. Throughout his career, he has held significant roles, including as the coordinator of the National Reference Center for Renal Cancer Surgery at Hospital La Magdalena . Although information regarding awards received is unavailable, his contribution to the field of urology is remarkable. Furthermore, Dr. Pontones Moreno has been a member of several scientific societies, including the Spanish Association of Urology and the European Association of Urology, reflecting his commitment to the advancement of medicine. His experience and dedication solidify his position as a prominent figure in his specialty.
Professional Details
Hospital Quirónsalud Valencia
SPECIALIST PHYSICIAN UROLOGY
January 2000
IVESP
PROFESSOR OF POSTGRADUATE COURSES
January 2000
Hospital La Magdalena
COORDINATOR IN CHARGE OF THE NATIONAL REFERENCE CENTER
January 1994
Hospital Universitario y Politecnico La Fe
AREA SPECIALIST FACULTY (FEA)
January 1994
Hospital La Magdalena
SURGICAL TEAM LEADER
January 1994
Hospital La Magdalena
CO-DIRECTOR of the REFERENCE UNIT
January 1994
Another qualification
Postgraduate Course (IVESP)
Another qualification
Postgraduate Course (IVESP)
Facultad de Medicina de Valencia
Surgical Pathology-UROLOGY
Facultad de Medicina de Valencia
January 2011
Postgraduate Courses
IVESP
January 2000
Selective chemoprophylaxis guided by multifactorial analysis in superficial bladder carcinoma
Foundation for Urological Research (FIU) of the Asociación Española de Urología
TUGAMO STUDY: Utility of bone turnover markers in patients with prostate, kidney and bladder cancer with bone metastases
ZEUS Studio (CZOL446G DE08/SPCG No. 11)
Differential expression of the EPDR1 gene in isolated cells from urine and tissue of patients with bladder cancer
Universidad de Valencia
2017
MAK-BLA-202 Study on Immunotherapy in Superficial Bladder Carcinoma
MK-3475-992: A Phase 3, Randomized, Double-blind, Matching Placebo-controlled Clinical Trial to Study the Efficacy and Safety of Pembrolizumab (MK-3475) in Combination With Chemoradiotherapy (CRT) versus CRT Alone in Participants with Muscle-invasive Bladder Cancer (MIBC) (KEYNOTE-992)
MK3475-564: Phase III trial of pembrolizumab (MK-3475) treatment in the adjuvant setting for post-nephrectomy clear cell renal carcinoma.
Prospective, controlled, randomized, double-blind, multi-centre, multinational study on the safety and efficacy of 6% Hydroxyethyl starch solution (HES) versus an electrolyte solution in patients undergoing elective abdominal surgery. HC-G-H-1504.
2018
COMBAT Study (ARI-40005)
MODELING RISK FACTORS IN SUPERFICIAL BLADDER CARCINOMA. NOMOGRAMS FOR INDIVIDUALIZED PATIENT FOLLOW-UP
Department of Health of the Generalitat Valenciana
2008
Study on the prognostic factors of transitional carcinoma and development of mathematical models predictive of the recurrence of superficial bladder transitional carcinoma
Instituto de Matemática Multidisciplinar de la Universidad Politécnica de Valencia
INTERNATIONAL EPIDEMIOLOGICAL STUDY ON THE DIAGNOSIS AND TREATMENT OF PATIENTS WITH NON-MUSCLE-INVASIVE BLADDER TUMOR. Code COM-TVS-2015-01
2017
Make an appointment with this professional
Vídeos de
Consulta el contenido multimedia de este profesional.
Hospitals
Book an appointment now at one of our hospitals.
Hospital Quirónsalud Valencia
Avda. Blasco Ibáñez, 14
46010 Valencia
Articles on
Browse the latest articles on Tu canal de salud.
¿No tienes seguro de salud?
Con nuestros Planes de Salud Quirónsalud Connect tendrás un médico de medicina general todos los días las 24 horas. Y además gestor personal y medición facial de constantes vitales.